Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Harrow Health Inc (HROW)
NASDAQ:HROW
Harrow Health (HROW) Stock Price & Analysis
276 Followers
HROW Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$7.60 - $25.58
Previous Close$25.01
Volume319.67K
Average Volume (3M)471.36K
Market Cap
$884.90M
Enterprise Value$992.28M
Total Cash (Recent Filing)$82.77M
Total Debt (Recent Filing)$190.50M
Price to Earnings (P/E)―
Beta0.61
Next Earnings
Aug 06, 2024EPS Estimate
-$0.18Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.91
Shares Outstanding35,382
10 Day Avg. Volume430,234
30 Day Avg. Volume471,358
Standard Deviation0.21
R-Squared0.05
Alpha0.03
Financial Highlights & Ratios
Price to Book (P/B)-0.01
Price to Sales (P/S)0.00600
Price to Cash Flow (P/CF)-0.20
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue9.14
Enterprise Value/Gross Profit10.96
Enterprise Value/Ebitda85.81
Forecast
1Y Price Target
$27.00Price Target Upside7.96% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering3
Harrow Health News
Bulls Say, Bears Say
Bulls Say
Commercial ExpansionVEVYE commercial lives' coverage expanded dramatically, resulting in total and new prescription growth with high refill rates, which is expected to significantly contribute to future sales.
Product Supply AgreementsIHEEZO supply agreements were secured with seven multi-practice strategic accounts, representing roughly 10% of the total IVT and cataract surgery procedures performed annually.
Revenue Growth PotentialManagement observed strong trends indicative of a high likelihood of Harrow Health executing on a strong revenue growth trajectory and increased visibility into healthy cash flow generation potential.
Bears Say
Market RedevelopmentInvestment-heavy market re-development phase could maintain choppiness to product segment revenue and cash flow positivity metrics.
Product LaunchUncertainty remains due to early stage of product launch and impact of free drug sampling.
Product RevenueInvestment-heavy market redevelopment phase could maintain choppiness in short-term product revenue and cash flow positivity.
---
Ownership Overview
22.42% Insiders
15.12% Mutual Funds
10.58% Other Institutional Investors
51.89% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
HROW FAQ
What was Harrow Health Inc’s price range in the past 12 months?
Harrow Health Inc lowest stock price was $7.60 and its highest was $25.58 in the past 12 months.
What is Harrow Health Inc’s market cap?
Currently, no data Available
When is Harrow Health Inc’s upcoming earnings report date?
Harrow Health Inc’s upcoming earnings report date is Aug 06, 2024 which is in 16 days.
How were Harrow Health Inc’s earnings last quarter?
Harrow Health Inc released its earnings results on May 13, 2024. The company reported -$0.38 earnings per share for the quarter, missing the consensus estimate of -$0.218 by -$0.162.
Is Harrow Health Inc overvalued?
According to Wall Street analysts Harrow Health Inc’s price is currently Undervalued.
Does Harrow Health Inc pay dividends?
Harrow Health Inc does not currently pay dividends.
What is Harrow Health Inc’s EPS estimate?
Harrow Health Inc’s EPS estimate is -$0.18.
How many shares outstanding does Harrow Health Inc have?
Harrow Health Inc has 35,381,935 shares outstanding.
What happened to Harrow Health Inc’s price movement after its last earnings report?
Harrow Health Inc reported an EPS of -$0.38 in its last earnings report, missing expectations of -$0.218. Following the earnings report the stock price went up 34.548%.
Which hedge fund is a major shareholder of Harrow Health Inc?
Among the largest hedge funds holding Harrow Health Inc’s share is Private Capital Management, LLC. It holds Harrow Health Inc’s shares valued at 40M.
---
Harrow Health Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$27.00 (7.96% Upside)
$27.00 (7.96% Upside)
Blogger Sentiment
Bullish
HROW Sentiment 100%
Sector Average 71%
Sector Average 71%
Hedge Fund Trend
Increased
By 254.3K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Bought Shares
Worth $404.0K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Positive
Last 7 Days ▲ 1.5%
Last 30 Days ▲ 5.1%
Last 30 Days ▲ 5.1%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
16.16%
12-Months-Change
Fundamentals
Return on Equity
-76.44%
Trailing 12-Months
Asset Growth
35.66%
Trailing 12-Months
Company Description
Harrow Health Inc
Harrow Health Inc is an ophthalmology-focused pharmaceutical company. The company is specialized in the development, production, and sale of medications that offer competitive advantages and serve unmet needs in the marketplace. Its cornerstone of ophthalmology program consists of proprietary Dropless Therapy injectable and LessDrops topical formulations that are designed to address patient compliance issues and provide other compelling medical and economic benefits.
---
HROW Company Deck
---
HROW Earnings Call
Q1 2024
0:00 / 0:00
---
HROW Stock 12 Month Forecast
Average Price Target
$27.00
▲(7.96% Upside)
Technical Analysis
Amneal Pharmaceuticals
―
Trevena
―
Eagle Pharmaceuticals
―
Arrowhead Pharmaceuticals
―
Best Analysts Covering HROW
1 Year
1 Year Success Rate
9/10 ratings generated profit
1 Year Average Return
+84.23%
reiterated a buy rating last month
Copying Mayank Mamtani's trades and holding each position for 1 Year would result in 90.00% of your transactions generating a profit, with an average return of +84.23% per trade.
---